Exhaled breath markers of alveolar macrophage activity in sarcoidosis (Q40743944)

23 September 2017

title

Exhaled breath markers of alveolar macrophage activity in sarcoidosis (English)

1 reference

23 September 2017

1 reference

Nitin Mohan

1

1 reference

23 September 2017

Rabeya Akter

2

1 reference

23 September 2017

Katherine Bryant

3

1 reference

23 September 2017

Cristan Herbert

4

1 reference

23 September 2017

Sharron Chow

5

1 reference

23 September 2017

Paul S Thomas

6

1 reference

23 September 2017

publication date

23 March 2016

1 reference

23 September 2017

published in

Inflammation Research

1 reference

23 September 2017

volume

65

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

471-478

1 reference

23 September 2017

cites work

Pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Sarcoidosis: the nephrologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

21 January 2018

Statement on Sarcoidosis

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Exhaled breath condensate: methodological recommendations and unresolved questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

A Simple Method for Estimating Respiratory Solute Dilution in Exhaled Breath Condensates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Calcium and Magnesium in Exhaled Breath Condensate of Children with Endogenous and Exogenous Airway Acidification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Collection devices influence the constituents of exhaled breath condensate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Immunopathogenesis of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

The effect of temperature on exhaled breath condensate collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

Exhaled breath condensate: a comprehensive update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00011-016-0929-Y

The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study

21 January 2018

1 reference

12 December 2020

KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease

1 reference

12 December 2020

[Markers of fibrosis and inflammation in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis -- a pilot study]

1 reference

12 December 2020

Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis

1 reference

12 December 2020

Tumor necrosis factor production by human sarcoid alveolar macrophages

1 reference

12 December 2020

Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis

1 reference

12 December 2020

Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers

1 reference

12 December 2020

The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance

1 reference

12 December 2020

10.1007/S00011-016-0929-Y

Identifiers

DOI

1 reference

23 September 2017

1 reference